The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

J Hosp Infect. 2018 Sep:100 Suppl 1:S1-S31. doi: 10.1016/j.jhin.2018.07.037.
No abstract available

Keywords: Clostridium difficile; faecal transplant; inflammatory bowel disease; microbiota.

Publication types

  • Guideline

MeSH terms

  • Advisory Committees
  • Anti-Infective Agents / therapeutic use
  • Clostridium Infections / drug therapy
  • Clostridium Infections / therapy*
  • Communicable Diseases
  • Evidence-Based Medicine
  • Fecal Microbiota Transplantation* / methods
  • Fecal Microbiota Transplantation* / standards
  • Feces
  • Gastroenterology
  • Humans
  • Recurrence
  • Severity of Illness Index
  • Societies, Medical
  • United Kingdom

Substances

  • Anti-Infective Agents